Clinicopathological significance of lymphangiogenesis and tumor lymphovascular invasion in indonesian breast cancers

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 2, 2013, Pages 997-1001

  Widodo, Irianiwati ^a   Ferronika, Paranita ^a   Harijadi, Ahmad ^a   Ediati Triningsih, F X ^a   Utoro, Totok ^a   Soeripto, ^a  

^a GADJAH MADA UNIVERSITY   (Indonesia)

Author keywords

Age; ER PR status; Grade; Her 2 status; LVD; LVI; Lymphnode status; Tumor size; VEGF C

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ERBB2 PROTEIN, HUMAN; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; PROTEIN P53; TUMOR MARKER; VASCULOTROPIN C; VEGFC PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BREAST TUMOR; CELL PROLIFERATION; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; INDONESIA; LYMPH NODE METASTASIS; LYMPH VESSEL; LYMPHANGIOGENESIS; METABOLISM; MIDDLE AGED; PATHOLOGY; VASCULARIZATION;

ADULT; AGED; BREAST NEOPLASMS; CELL PROLIFERATION; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INDONESIA; LYMPHANGIOGENESIS; LYMPHATIC METASTASIS; LYMPHATIC VESSELS; MIDDLE AGED; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 84877638347     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.2.997     Document Type: Article

References (21)

1. Beasley NJ, Prevo R, Banerji S, et al, (2002). Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer. Cancer Res, 62, 1315-20.
2. Botting SK, Fouad H, Elwell K, Rampy BA, Salama SA, Freeman DH, Diaz-nastia CR. 2010. Prognostic significance of peritumoral lymphatic vessel density and vascular endothelial growth factor receptor3 in invasive squamous cell cervical cancer. Transl Oncol, 3, 170-5.
3. Donegan WL (1997). Tumor related prognostic factor for breast cancer. Cancer J Clin, 47, 28.
4. El Ghohary YM, Metwally G, Saad RS, et al, (2008). Prognostic significance of intratumoral and peritumoral lymphatic density and blood vessel density in invasive breast carcinomas. Am J Clin Pathol, 129, 578-86.
5. Furudoi A, Tanaka S, Haruma K, et al, (2002). Clinicalsignificance of VEGF-C and angiogenesis at the deepest invasive of advance colorectal carcinoma. Oncology, 62, 157-66.
6. Kinoshita J, Kitamura K, Kabashima A, et al, (2001). Clinical significancer of vascular endothelial growth factors-C in breast cancer. Breast Cancer Res Treat, 66, 159-64.
7. Marinho VFZ, Metze K, Sanches FS, Rocha GFS, Gobbi H (2008). Lymph vascular invasion in invasive mammary carcinomas indentified by the endothelial lymphatic marker D2-40 is associated with other indicatiors of poor prognosis. BMC Cancer, 8, 64.
8. Nakamura Y, Yasuoka H, Tsujimoto M, et al, (2003). Clinicopathological significance of VEGF-C in breast carcinoma with long-term follow-up. Mod Pathol, 16, 309-14.
9. Ogawa E, Takenaka K, Yanagihara K, et al, (2004). Clinical significance of VEGF-C status in tumour cells and stromal macrophages in non-small cell lung cancer patients. Br J Cancer, 91, 498-503.
10. Papper MS (2001). Lymphangiogenesis and tumor metastasis: myth or reality? Clin Cancer Res, 7, 462-8.
11. Schoppmann SF, Bayer G, Aumayr K, et al, (2004). Prognostic value of lymphangiogenesis and lymphovascular invasion in invasion in invasive breast cancer. Ann Surg, 240, 306-12.
12. Schoppmann SF, Fenzl A, Nagy K, et al, (2006). VEGF-C expressing TAMs in lymph node positive breast cancer: impact on lymphangiogenesis and survival. Surgery, 139, 839-46.
13. Sundar SS, Ganesa TS (2007). Role of lymphangiogenesis in Cancer. J Clin Oncol, 25, 4298-307.
14. Tavassoli FA, dan Devilee P, (2003). WHO Classification of tumours. Pathology and genetics. Tumours of the breast and female genital organs, IARC Press, Lyon.
15. Teguh A, Harijadi, Ahmad G, (2000) Correlation of clinical, pathological status, hormone receptor and C-erb-2 oncoprotein in breast cancer patients. Jpn J Cancer Chemother, 27, 600-6.
16. Tezuka K, Onoda N, Takashima T, et al, (2007). Prognostic significance of lymphovascular invasion diagnosed by lymphatic endothelium immunostaining in breast cancer patients. Oncol Rep, 17, 997-1003.
17. Teramoto S, Arihiro K, Koseki M, et al, (2008), Role of VEGF-C and D mRNA in breast cancer. Hiroshima J Med Sci, 57, 73-8
18. Yavuz S, Paydas S, Disel U, Zorludemir S, Erdogan S, (2005). VEGF-C expression in breast cancer: clinical importance. Adv Ther, 22, 368-77.
19. Yokoyama Y, Charnock-Jones DS, Licence D, et al, (2003). VEGF-D is an independent prognostic factor in epithelial ovarian carcinoma. Br J Cancer, 88, 237-44.
20. Yonemura Y, Endo Y, Fijuta H, et al, (1999). Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer. Mol Oncol, 5, 1823-9.
21. Zhang XH, Huang DP, Guo GL, et al, (2008) Coexpression of VEGF and COX-2 and its association with lymphangiogenesis in human breast cancer. BMC Cancer, 8, 1-8.